Research Center: Texas Center For Drug Development
Location: 6550 Mapleridge St. Suite 201 Houston Texas, 77081

Background

Around 3.5 million people in the United States are diagnosed with Schizophrenia. It’s a severely debilitating psychotic disorder that can have long lasting impairment.

This study is investigating the efficacy and safety of a long acting injectable medication in patients with schizophrenia. This opportunity would enable you to receive, at no cost, Laboratory Tests, Electrocardiograms (ECGs), Physical Examinations and Medical Care, Investigational Medication and Compensation for Time & Travel.

This study seeks men and women who currently suffer from Schizophrenia. Participants are required to attend 11 study visits and up to 14 phone calls at the research site over a 10 month period and will be compensated $60.50 for each clinic visit and $30 for scheduled phone calls while participating in this study.

Why Participate?

• Your participation may provide information that is useful to our understanding of the study drug and schizophrenia.
• You will be helping to advance medical research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Men and women  who suffer from Schizophrenia
• Able to attend study visits at the research site over approximately 10 months